MedTrace Logo

Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA

NCT03054064 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2020-04-07

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and effectiveness of the Indego exoskeleton as a gait training tool for individuals with hemiplegia due to Cerebrovascular Accident (CVA).

Conditions

  • Cerebrovascular Accident (CVA)
  • Stroke
  • Hemiplegia

Interventions

DEVICE

Indego Exoskeleton

Six study sessions including five Indego training sessions over two weeks.

Sponsors & Collaborators

  • Shepherd Center, Atlanta GA

    collaborator OTHER

  • Cedars-Sinai Medical Center

    collaborator OTHER

  • Sheltering Arms Physical Rehabilitation Hospitals

    collaborator OTHER

  • Shirley Ryan AbilityLab

    collaborator OTHER

  • Kessler Foundation

    collaborator OTHER

  • St. Charles Hospital

    collaborator UNKNOWN

  • TIRR Memorial Hermann

    collaborator OTHER

  • Rusk Rehabilitation

    collaborator UNKNOWN

  • Parker Hannifin Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-21
Primary Completion
2017-12-28
Completion
2018-01-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03054064 on ClinicalTrials.gov